Adoptive transfer of reprogrammed patient cd4+ t cells
Adoptive transfer of reprogrammed patient cd4+ t cells has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jan 5, 2026: “Awakening intracellular immunity for functional HIV cure”.
1 paper studies it1 findingUpdated
- 1 lab in 1 country
- Funder: University College London
- Animals1
What did studies of Adoptive transfer of reprogrammed patient cd4+ t cells find?
1Studies of Adoptive transfer of reprogrammed patient cd4+ t cells measured 1 outcome; the most studied are HIV DNA (1 study).
HIV DNA
downin mice1
1 study
HIV DNA
downin mice1
Adoptive transfer of reprogrammed patient cd4+ t cells decrease HIV DNA in mice.
“adoptive transfer of reprogrammed patient CD4+ T cells, or in vivo reprogramming of murine T cells, eliminated HIV DNA across reservoirs”
Animalsin humanised mice and in vivo reprogramming
Awakening intracellular immunity for functional HIV cure
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Latest
1 paper in 12 monthsbioRxiv
Awakening intracellular immunity for functional HIV cure
Preprint: experiments in miceBlood and immune system